The COVID-19 pandemic dramatically heightened awareness of airborne transmission risks and created urgent demand for continuous pathogen monitoring and disinfection in public spaces—hospitals, schools, transport hubs, offices, and venues.
A single bioaerosol—produced by a cough—can carry over 1 million coronavirus particles. Yet, no technology currently exists to continuously monitor airborne pathogens in real time.
300,000 additional healthcare-associated infections (HAIs) occur annually in the UK
£2 billion+ cost to NHS England each year (2017 estimate)
Frequent airborne transmission of:
“Superbugs” like MRSA and C. difficile
Common viruses such as Influenza, COVID-19, RSV
Bacterial threats like Aspergillus and Staphylococcus
Mechanical ventilation systems are contributing to pneumonia spread—case fatality rate: 40%
Current methods rely on manual air sampling and lab testing, causing delays and limiting responsiveness
Aerosolised pathogens remain difficult to detect using existing technology
House of Commons Public Accounts Committee, Reducing Healthcare Associated Infection in Hospitals in England, 2008-09
-J. F. Guest, et al. “Modelling the annual NHS costs and outcomes attributable to healthcare-associated infections in England.” BMC Open, (2020)
-S. S. Bhimji and W. G. Gossman, Precautions, Airborne, StatPearls Publishing, 2018.
-C. C. Wang, K. A. Prather, J. Sznitman, J. L. Jimenez, S. S. Lakdawala, Z. Tufekci and L. C. Marr, Science (2021).
The COVID-19 pandemic dramatically heightened awareness of airborne transmission risks and created urgent demand for continuous pathogen monitoring and disinfection in public spaces—hospitals, schools, transport hubs, offices, and venues.
A single bioaerosol—produced by a cough—can carry over 1 million coronavirus particles. Yet, no technology currently exists to continuously monitor airborne pathogens in real time.
House of Commons Public Accounts Committee, Reducing Healthcare Associated Infection in Hospitals in England, 2008-09
-J. F. Guest, et al. “Modelling the annual NHS costs and outcomes attributable to healthcare-associated infections in England.” BMC Open, (2020)
-S. S. Bhimji and W. G. Gossman, Precautions, Airborne, StatPearls Publishing, 2018.
-C. C. Wang, K. A. Prather, J. Sznitman, J. L. Jimenez, S. S. Lakdawala, Z. Tufekci and L. C. Marr, Science (2021).
Real-Time Intelligentv Air Quality – Protecting Health, Enhancing Safety.
There is no real-time solution to continuously detect and respond to airborne biological threats. In high-risk environments, this gap costs lives, increases infections, and places massive strain on health systems.
Pinpoint’s iAQ system is designed to fill this gap—with integrated biosensing, filtration, and intelligent air monitoring for rapid, autonomous detection and action.
Real-Time Intelligentv Air Quality – Protecting Health, Enhancing Safety.
There is no real-time solution to continuously detect and respond to airborne biological threats. In high-risk environments, this gap costs lives, increases infections, and places massive strain on health systems.
Pinpoint’s iAQ system is designed to fill this gap—with integrated biosensing, filtration, and intelligent air monitoring for rapid, autonomous detection and action.
A New Standard in Airborne Pathogen Detection
At Pinpoint Medical, we're developing a cutting-edge solution to detect and diagnose airborne pathogens (bioaerosols) in hospitals and public environments—responding to growing government focus on air quality compliance and infection control.
Our proprietary biosensor technology integrates seamlessly with the iAQ filtration system, enabling real-time, point-of-care monitoring of airborne threats across a wide range of settings including hospitals, transport hubs, schools, care homes, and residential buildings.
The iAQ platform is modular and highly adaptable—designed to retrofit into existing ventilation systems or operate as a standalone, mobile unit. It supports cloud-based integration, allowing for centralised, real-time monitoring across multiple locations.
While our biosensing technology is in advanced development, our filtration units are production-ready and available for immediate scale-up and deployment.
We are also engaging with established third-party providers across healthcare and environmental sectors, enabling broad commercial application and market expansion through integration and licensing opportunities.
A New Standard in Airborne Pathogen Detection
At Pinpoint Medical, we're developing a cutting-edge solution to detect and diagnose airborne pathogens (bioaerosols) in hospitals and public environments—responding to growing government focus on air quality compliance and infection control.
Our proprietary biosensor technology integrates seamlessly with the iAQ filtration system, enabling real-time, point-of-care monitoring of airborne threats across a wide range of settings including hospitals, transport hubs, schools, care homes, and residential buildings.
The iAQ platform is modular and highly adaptable—designed to retrofit into existing ventilation systems or operate as a standalone, mobile unit. It supports cloud-based integration, allowing for centralised, real-time monitoring across multiple locations.
While our biosensing technology is in advanced development, our filtration units are production-ready and available for immediate scale-up and deployment.
We are also engaging with established third-party providers across healthcare and environmental sectors, enabling broad commercial application and market expansion through integration and licensing opportunities.
Intelligent Air Quality (iAQ)
A New Standard in Airborne Pathogen Detection
At Pinpoint Medical, we're developing a cutting-edge solution to detect and diagnose airborne pathogens (bioaerosols) in hospitals and public environments—responding to growing government focus on air quality compliance and infection control.
Our proprietary biosensor technology integrates seamlessly with the iAQ filtration system, enabling real-time, point-of-care monitoring of airborne threats across a wide range of settings including hospitals, transport hubs, schools, care homes, and residential buildings.
The iAQ platform is modular and highly adaptable—designed to retrofit into existing ventilation systems or operate as a standalone, mobile unit. It supports cloud-based integration, allowing for centralised, real-time monitoring across multiple locations.
While our biosensing technology is in advanced development, our filtration units are production-ready and available for immediate scale-up and deployment.
We are also engaging with established third-party providers across healthcare and environmental sectors, enabling broad commercial application and market expansion through integration and licensing opportunities.
Disinfection
Monitoring
Our biosensor platform called Disposable Plasmonic Assays, or DPAs, are proprietary nanophotonic technology that is mass manufacturable using methods similar to BluRay production.
Disposable Plasmonic Assays
Ceramic Photocatalytic Filters
No Differential Pressure Drop
Using UV-A and UV-C, these oxide coated porous ceramic filters don’t just filter the pathogens, they destroy them on contact.
High Air-Flow Rates with Metamaterial Noise Cancellation
Disinfection
Monitoring
Our biosensor platform called Disposable Plasmonic Assays, or DPAs, are proprietary nanophotonic technology that is mass manufacturable using methods similar to BluRay production.
Disposable Plasmonic Assays
Ceramic Photocatalytic Filters
No Differential Pressure Drop
Using UV-A and UV-C, these oxide coated porous ceramic filters don’t just filter the pathogens, they destroy them on contact.
High Air-Flow Rates with Metamaterial Noise Cancellation
"Just like our water supply, the air we breathe is a vital resource—one that must be monitored, protected, and intelligently managed. As global travel accelerates, populations grow, and infectious diseases continue to evolve, the need for robust environmental monitoring and advanced air purification has never been more urgent.
Pinpoint Medical’s iAQ was developed with this mission at its core. It is designed to integrate seamlessly into everyday environments—delivering safe, breathable air, while redefining how we detect and respond to airborne threats. As the landscape continues to evolve, so will our technology."
Dr. Affar S. Karimullah
Chief Technology Officer, Pinpoint Medical
"Just like our water supply, the air we breathe is a vital resource—one that must be monitored, protected, and intelligently managed. As global travel accelerates, populations grow, and infectious diseases continue to evolve, the need for robust environmental monitoring and advanced air purification has never been more urgent.
Pinpoint Medical’s iAQ was developed with this mission at its core. It is designed to integrate seamlessly into everyday environments—delivering safe, breathable air, while redefining how we detect and respond to airborne threats. As the landscape continues to evolve, so will our technology."
Dr. Affar S. Karimullah
Chief Technology Officer, Pinpoint Medical
Phone: +44 (0)7796 777 739
Email: info@pinpointmedical.co.uk
Address: St Colmes, Ballinluig, Pitlochry, United Kingdom, PH9 0NR
Phone: +44 (0)7796 777 739
Email: info@pinpointmedical.co.uk